Are there any upcoming or ongoing clinical trials I can join?

Yes — here's what's recent and what's active.

PMDD (concluded May 2026): our collaboration with Queen Mary University of London found that 82.4% of women experienced a statistically significant reduction in luteal-phase anxiety with the Samphire Headband. Findings are being written up for peer review and are under review by regulatory authorities for the formal therapeutic approval of the Samphire Headband as a PMDD treatment option.

Endometriosis & chronic pelvic pain: our pilot with the NHS in London is ongoing, with the goal of NHS trust reimbursement for users in need from 2028 onwards.

Active studies on PMDD follow-up, endometriosis, chronic pelvic pain, and perimenopausal symptoms continue with NHS, UCLH, and international partners. Sign up to our newsletter or follow us on Instagram for announcements. You can see the full list of current trials on our website here.

Share this article

Still have questions? support@samphireneuro.com